Preserving the Right to Quality Care: Spotlight on Autoimmune Conditions


Advocacy Workshop on Protecting Coverage and Access to Individualized Treatments and Preferred Providers


Wednesday, June 6, 2018

12:00 p.m. – 1:30 p.m.

The Westin Boston Waterfront
Harbor Ballroom III
425 Summer Street
Boston, MA 02210

Aimed Alliance invites organizations to attend Preserving the Right to Quality Care: Spotlight on Autoimmune Conditions, a lunchtime advocacy workshop that focuses on changing health care policies that currently keep millions of patients from getting timely and effective care for autoimmune conditions, such as rheumatoid arthritis, psoriasis, lupus, Crohn’s disease, and type 1 diabetes.

Hosted by the Aimed Alliance, the workshop offers solutions on managing high copays, coverage denials, and insurance policies that delay treatment, force individuals to try less effective therapies, and keep patients from seeing the health care providers they trust.

The workshop is free and includes complimentary lunch.

View Workshop Agenda 

RSVP by Wednesday, May 30th


Click to View Agenda

Topic areas include:

  • Examining the insurance practices that limit access to prescribed treatments and services, such as adverse tiering, nonmedical switching, prior authorization, step therapy, and insurer’s clinical pathways
  • Ensuring individuals have sufficient access to the health care providers of their choice
  • Working with employers and human resource professionals to negotiate appropriate health plans
  • Selecting health insurance plans that provide adequate coverage
  • Understanding when insurance procedures violate federal and state consumer protection laws
  • Discussing recent legislative and regulatory developments that impact coverage and access
  • Understanding how to use insurers’ appeals process to gain access to health care treatment and services
  • Learning about strategies and resources to improve access to quality health care


RSVP by Wednesday, May 30th

For more information contact Nellie Wild at



Comments are closed.